 STOCKHOLM, Jan. 12, 2021 PRNewswire -- Medivir AB publ Nasdaq Stockholm: MVIR today announced that it has entered into an exclusive licensing agreement, through which IGM Biosciences, Inc. Nasdaq: IGMS, will receive global, exclusive development rights for birinapant, a... 